Konan Medical USA Inc. Release: Six Month Data Reported for WAVE I Study of Renal Denervation Therapy for Hypertension at EuroPCR Meeting in Paris

Published: May 23, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Kona Medical announced that three and six month results from the WAVE I study were presented today at the late-breaking clinical trials session of EuroPCR in Paris by Robert Whitbourn, MD, of St. Vincent’s Hospital in Melbourne, Australia. WAVE I is a first-in-man study evaluating the safety and efficacy of Kona Medical’s Surround Sound® Renal Denervation System for the treatment of resistant hypertension.

Help employers find you! Check out all the jobs and post your resume.

Back to news